Grey

Trumid Reports October Performance

Retrieved on: 
Tuesday, November 7, 2023
ADV, RFQ, Anonymous, Grey, Cryptocurrency

NEW YORK, Nov. 7, 2023 /PRNewswire-PRWeb/ -- Trumid, a financial technology company and fixed income electronic trading platform, today announced record trade volume and user participation highlights for October 2023.

Key Points: 
  • Over 1,000 traders transacted on Trumid for the tenth consecutive month.
  • Trumid PT and RFQ had a record month for traded volumes, both up around 25% month-on-month.
  • Over 950 unique traders have utilized Trumid RFQ since launch with nearly 75% of them executing a trade.
  • Trumid PT saw a record number of lists traded in the month of October.

INmune Bio Inc. Announces Third Quarter 2023 Results and Provides Business Update

Retrieved on: 
Wednesday, November 1, 2023
Research, AD, Food, Health care, Biomarker, ATCC, Macrophage, World Intellectual Property Organization, Data, White matter, Phase, MHRA, MRI, MDS, CELL, Hereditary leiomyomatosis and renal cell cancer syndrome, Prostate cancer, Dementia, China International Search and Rescue Team, ATCC (company), Phagocytosis, EEG, Cancer, Patient, MS, BOCA, Human, Neurodegenerative disease, Conference, CTA, Patent Cooperation Treaty, AAIC, PCT, NK, Brain, Remyelination, Grey, AML, Carcinoma, FDA, IND, Medication, CNS, Treatment-resistant depression, Drug development, Pharmacotherapy, Neuroinflammation, WIPO, Cross, Cognition, Vaccine, Pharmaceutical industry, Medical imaging, Cryptocurrency, Health, Immunotherapy, Disease

BOCA RATON, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2023 and provides a business update.

Key Points: 
  • BOCA RATON, Fla., Nov. 01, 2023 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announces its financial results for the quarter ended September 30, 2023 and provides a business update.
  • Recruitment of the trial is increasing and the company anticipates results of the Phase II program towards the end of 2024.
  • Other expense was approximately $0.0 million for the quarter ended September 30, 2023, compared to approximately $0.3 million during the quarter ended September 30, 2022.
  • Please ask for the INmune Bio Third Quarter Conference Call when reaching an operator.

Knife River Corporation Reports Third Quarter Earnings

Retrieved on: 
Monday, November 6, 2023
Building Systems, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, Adjustment, Ratio, EBITDA, GAAP, Infrastructure Investment and Jobs Act, Energy, Transport, Culture, EDGE, Grey, Renewable energy, Retail

“Our third quarter 2023 revenue, net income, EBITDA and Adjusted EBITDA were better than any quarter in Knife River history.

Key Points: 
  • “Our third quarter 2023 revenue, net income, EBITDA and Adjusted EBITDA were better than any quarter in Knife River history.
  • “I would like to thank our entire Knife River team for their continued discipline in executing our EDGE plan to increase Adjusted EBITDA margins and deliver on our strategic goals,” Gray said.
  • Price increases outpaced costs for the quarter and positively contributed to our margins, as we made further progress toward our previously stated margin-expansion goals.
  • “As of August, nearly $80 billion in funding from the Infrastructure Investment and Jobs Act has been allocated to projects in states where Knife River operates.

New York Festivals Appoints Strategic Marketing Leader Jennifer Vizina as Executive Director of NYF's Health Awards

Retrieved on: 
Thursday, October 19, 2023
Vilniaus prekyba, Grey, Strategic planning, Merkley+Partners, SVP, New business development, Advertising, Health, Energy Star, Creativity, Canada Gairdner Global Health Award, Grand, EPA, Delta Air Lines, Growth, Wells Fargo, Taco Bell, Bayer, Executive, Pizza Hut, Lead, Song (airline), Film industry, Pharmaceutical industry, Management, Rare-earth element, Health care, Pharma, New York Festivals, Vižina

NEW YORK, Oct. 19, 2023 /PRNewswire/ -- The New York Festivals has appointed strategic marketer Jennifer Vizina to the position of NYF Health Awards Executive Director.

Key Points: 
  • NEW YORK, Oct. 19, 2023 /PRNewswire/ -- The New York Festivals has appointed strategic marketer Jennifer Vizina to the position of NYF Health Awards Executive Director.
  • As Executive Director of the 2024 NYF Health Awards, Ms. Vizina will take the helm charting a visionary course for the competition's growth and development within the Healthcare & Wellness/Pharma sector.
  • - Scott Rose, President of NYF Advertising Awards Competition
    "I am honored to join the distinguished team at New York Festivals.
  • I am excited to lead and guide the competition towards reaching new milestones of excellence" said Jennifer Vizina, Executive Director, New York Festivals Health Awards.

INmune Bio Inc. Presents New Biomarker and Feasibility Data from Phase 1b Study Supporting the Use of XPro™ to Treat Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Retrieved on: 
Tuesday, October 17, 2023
Cross, Drug development, Biology, Brain, Trial of the century, CNS Drugs (journal), Remyelination, Proteome, Neurology, MOA, Clinical trial, Pharmacotherapy, Disease, EEG, CSF, Diffusion, Tau, Grey, MRI, Neuroinflammation, Patient, Cumulus cloud, Medical imaging, Pharmaceutical industry

Boca Raton, Florida, Oct. 17, 2023 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, highlights some important findings from data presented at the 16th annual Clinical Trial in Alzheimer’s Disease (CTAD) to be held October 24-27 in Boston, MA.

Key Points: 
  • INmune is enrolling AD patients into a global, blinded, randomized Phase II trial.
  • “The Phase Ib trial was designed to demonstrate that XPro™ reverses neuroinflammation and has been confirmed by previously presented data ,” said CJ Barnum Ph.D., VP of CNS Drug Development at INmune Bio.
  • P055: Changes in cortical microstructure in brain regions associated with cognitive status and disease duration after short-term treatment with XPro1595 for Alzheimer’s disease.
  • A goal of our Phase II study in Early AD patients is to correlate these biologic changes with cognitive function.”

Texas Methodist Foundation Names Pamela A. Gray as Director of Philanthropy

Retrieved on: 
Tuesday, October 17, 2023
Other Philanthropy, Religion, Finance, Professional Services, Philanthropy, Consumer, Fund Raising, Foundation, DAV, Multimedia, National Multiple Sclerosis Society, Boys & Girls Club, Organization, University, Data management, Alzheimer's disease, Rice University, Love, Baby boomers, Alzheimer's Association, Grey, Disability, AMVETS, Whaling, Hospital

Texas Methodist Foundation is pleased to announce Pamela A.

Key Points: 
  • Texas Methodist Foundation is pleased to announce Pamela A.
  • View the full release here: https://www.businesswire.com/news/home/20231017064168/en/
    Pamela Gray is named Director of Philanthropy for Texas Methodist Foundation.
  • "Planned giving is the most important way churches and nonprofits can build a sustainable future,” said Justin Gould, Chief Philanthropy Officer, Texas Methodist Foundation.
  • Adding Pamela to our team enables Texas Methodist Foundation to serve more donors and build their giving legacies."

Gray Promotes Jason Hall to Vice President

Retrieved on: 
Wednesday, October 11, 2023
NYSE, Olympic Games, Organization, Telemundo, Gray Television, Estrella Media, Growth, Univision, Grey

ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray”) (NYSE: GTN) announced the promotion of Jason Hall to Vice President of Spanish Media Sales, GrayTV Telemundo Station Group.

Key Points: 
  • ATLANTA, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Gray Television, Inc. (“Gray”) (NYSE: GTN) announced the promotion of Jason Hall to Vice President of Spanish Media Sales, GrayTV Telemundo Station Group.
  • Jason has over 20 years of Hispanic media experience building and managing sales organizations at Univision and Estrella Media.
  • “Jason’s Hispanic media sales expertise has been key to our Telemundo stations and overall sales success.
  • Jason’s track record with Gray has been invaluable, and we look forward to having him continue leading the charge for Spanish language media sales at Gray,” said Susan Sim Oh, VP of Strategy and Operations, GrayTV Telemundo Station Group.

WebMD Announces 16th Annual 2023 Health Heroes

Retrieved on: 
Wednesday, October 11, 2023
Diagnosis, Neuroscience, COVID-19, Osteochondrodysplasia, Skull, Bias, Family, The Children's Hospital, Machine learning, MS, Headache, COVID, Driving Force, Sickle cell disease, Rickets, Hospital, Bone tumor, Heart Trouble (album), CDC, Genetics, Disease, WHO, Patient, World Health Organization, Chordoma, Movement, Education, Long, CRISPR, HCA Healthcare, Clinical trial, Duke Cancer Institute, Public policy, Duke University, Genetic disorder, King Fahad Specialist Hospital Dammam, Bangladesh Technical Education Board, Jansen, Tissue, Volunteering, Korea Disease Control and Prevention Agency, Grey, Child, National Institutes of Health, Sarah Cannon Research Institute, Life, WebMD, Research, NIH, Cognitive science, Nursing, Pharmaceutical industry, Vaccine, MD, Long COVID

NEWARK, N.J., Oct. 11, 2023 /PRNewswire/ -- WebMD announced today the winners of the 2023 WebMD 16th annual Health Heroes Awards, which includes 4 categories: Lifelong Advocate, Patient Pioneer, Selfless Survivor and Driving Force.

Key Points: 
  • NEWARK, N.J., Oct. 11, 2023 /PRNewswire/ -- WebMD announced today the winners of the 2023 WebMD 16th annual Health Heroes Awards, which includes 4 categories: Lifelong Advocate, Patient Pioneer, Selfless Survivor and Driving Force.
  • "This year's Health Heroes are not only doing amazing things but they also have data or other measurable results that demonstrate the impact of their work," said Dr. John Whyte, Chief Medical Officer of WebMD.
  • With their findings in hand, they began meeting with public health leadership at the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and World Health Organization (WHO) to forge a path toward more research on Long COVID.
  • For additional information on the 2023 WebMD Health Heroes, click here: https://www.webmd.com/healthheroes/default.htm

BAFFIN ADVANCES ITS COLD WEATHER LEGACY WITH NEW CFL CAMPAIGN

Retrieved on: 
Tuesday, October 3, 2023
Bruce Trail, Hilltop Holdings Inc., Partnership, Common Cold Unit, Senior, CFL, Grey Cup, Adventure, Multimedia, Grey, AFL, History, Element, Cold, Philosophy, Weather, Commercial, Social media, Outdoor, Baffin

Developed in partnership with creative agency Elemental®, the campaign tells the story of the dedication and passion for thriving in cold weather shared by Baffin and the CFL, while revisiting the strong history of both.

Key Points: 
  • Developed in partnership with creative agency Elemental®, the campaign tells the story of the dedication and passion for thriving in cold weather shared by Baffin and the CFL, while revisiting the strong history of both.
  • The new "Cold Unites Us" campaign commemorates the long legacy Baffin and the CFL share in standing alongside fans as they experience the extraordinary, even through the intensity of a cold winter.
  • "Embracing the cold weather, rather than letting it deter you, can lead to some of life's most unforgettable experiences.
  • In November 2022, Baffin and the CFL launched a multi-year partnership, making Baffin the Official Boot of the league and the Grey Cup.

Origami Solar Appoints Michael Gray as Chief Operating Officer

Retrieved on: 
Monday, October 2, 2023
Origami, Aluminium, Steel, Grey, Carbon, ATI Technologies, Renewable energy

BEND, Ore., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Origami Solar , developers of a patent-pending steel frame for solar modules that lowers cost, dramatically reduces carbon emissions, and improves performance and value, announces the appointment of energy industry veteran, Michael Gray, to the new position of Chief Operating Officer (COO).

Key Points: 
  • BEND, Ore., Oct. 02, 2023 (GLOBE NEWSWIRE) -- Origami Solar , developers of a patent-pending steel frame for solar modules that lowers cost, dramatically reduces carbon emissions, and improves performance and value, announces the appointment of energy industry veteran, Michael Gray, to the new position of Chief Operating Officer (COO).
  • His most recent role was Chief Operating Officer at Infinitum Electric.
  • “Michael shares our vision of disrupting the monopolized solar supply chain that for decades has relied heavily on imported carbon-intensive Asian aluminum,” said Gregg Patterson, CEO of Origami Solar.
  • I am deeply motivated by Origami’s innovation in steel frame design that allows us to re-shore domestic solar frame production and strengthen energy independence,” said Michael Gray, COO of Origami Solar.